Accendra Health, Inc.
ACH
$2.04
$0.084.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 62.52% | 82.71% | -3,378.74% | 91.56% | -2,218.66% |
| Total Depreciation and Amortization | -53.40% | 7.91% | -2.87% | 434.04% | -129.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -277.09% | -91.45% | 7,092.32% | -96.88% | 7,560.52% |
| Change in Net Operating Assets | 238.55% | -270.48% | 208.45% | -274.23% | 376.13% |
| Cash from Operations | 139.52% | -558.71% | 207.25% | -149.39% | 160.01% |
| Capital Expenditure | 75.79% | 20.08% | -21.87% | -150.27% | 61.40% |
| Sale of Property, Plant, and Equipment | 33.95% | 1.35% | 7.32% | 213.83% | -183.65% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,316.02% | -13.43% | 66.36% | 38.31% | -219.53% |
| Cash from Investing | 822.19% | 25.42% | -9.79% | 7.85% | -92.37% |
| Total Debt Issued | -41.86% | -4.79% | 9.81% | -4.69% | 31.68% |
| Total Debt Repaid | 20.26% | 17.05% | -20.05% | 19.87% | -3.64% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | -242.85% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -203.03% | 7,105.71% | 79.87% | 68.89% | -1,908.93% |
| Cash from Financing | -164.88% | 471.30% | -65.83% | 315.28% | 78.41% |
| Foreign Exchange rate Adjustments | 479.41% | -102.70% | 132.29% | 141.41% | -220.09% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 862.66% | -275.18% | 75.56% | 139.11% | 87.04% |